Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.

Psychopharmacology bulletin Pub Date : 2025-02-03
Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi
{"title":"Hallucinogen-Persisting Perception Disorder in a 16-Year-Old Adolescent.","authors":"Anna Mori-Kreiner, Arpit Aggarwal, Meelie Bordoloi","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when the individual is sober. While there are several case reports of HPPD in adult patients, there is a scarcity of documented cases in children and adolescents. The purpose of this article is to highlight the presentation, diagnosis, and treatment of HPPD in a 16-year-old male patient.</p><p><strong>Methods: </strong>In this case report, the patient is a 16-year-old male with a history of major depressive disorder (MDD) and polysubstance use using Lysergic acid diethylamide (LSD), 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, cannabis, and benzodiazepines. He endorsed having auditory hallucinations and a heightened sense of hearing in between usage of MDMA for the past eight months and described auditory and visual hallucinations during his 5-day admission at the inpatient child psychiatric unit. Aripiprazole 5 mg was used as treatment for HPPD.</p><p><strong>Results: </strong>On review of literature, the first-line treatment for HPPD with clonidine and benzodiazepine has been documented by few case reports. Second generation antipsychotics are documented to be less effective with the exception of aripiprazole. The authors witnessed gradual improvement in the patient's symptoms with the use of aripiprazole, although it was not completely resolved during his hospital course.</p><p><strong>Conclusions: </strong>This case demonstrates the presentation of HPPD and efficacy of aripiprazole in an adolescent patient. The diagnosis was further complicated by the patient's history of polysubstance use, and determining a distinction from non-substance-induced psychotic disorders was paramount.</p>","PeriodicalId":94351,"journal":{"name":"Psychopharmacology bulletin","volume":"55 2","pages":"94-99"},"PeriodicalIF":0.0000,"publicationDate":"2025-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809505/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharmacology bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Hallucinogen-persisting Perception Disorder (HPPD) is a rare condition characterized by the re-experiencing of one or more perceptual symptoms that an individual experienced while intoxicated with a hallucinogenic substance when the individual is sober. While there are several case reports of HPPD in adult patients, there is a scarcity of documented cases in children and adolescents. The purpose of this article is to highlight the presentation, diagnosis, and treatment of HPPD in a 16-year-old male patient.

Methods: In this case report, the patient is a 16-year-old male with a history of major depressive disorder (MDD) and polysubstance use using Lysergic acid diethylamide (LSD), 3,4-Methylenedioxymethamphetamine (MDMA), psilocybin, cannabis, and benzodiazepines. He endorsed having auditory hallucinations and a heightened sense of hearing in between usage of MDMA for the past eight months and described auditory and visual hallucinations during his 5-day admission at the inpatient child psychiatric unit. Aripiprazole 5 mg was used as treatment for HPPD.

Results: On review of literature, the first-line treatment for HPPD with clonidine and benzodiazepine has been documented by few case reports. Second generation antipsychotics are documented to be less effective with the exception of aripiprazole. The authors witnessed gradual improvement in the patient's symptoms with the use of aripiprazole, although it was not completely resolved during his hospital course.

Conclusions: This case demonstrates the presentation of HPPD and efficacy of aripiprazole in an adolescent patient. The diagnosis was further complicated by the patient's history of polysubstance use, and determining a distinction from non-substance-induced psychotic disorders was paramount.

一名16岁青少年的致幻剂持续知觉障碍。
目的:致幻剂持续感知障碍(HPPD)是一种罕见的疾病,其特征是个体在清醒状态下被致幻剂麻醉后再次经历一种或多种感知症状。虽然有几例成人HPPD病例报告,但在儿童和青少年中记录的病例很少。本文的目的是强调一个16岁男性患者的HPPD的表现,诊断和治疗。方法:本病例报告患者为16岁男性,有重度抑郁症(MDD)病史,曾使用麦角酸二乙胺(LSD)、3,4-亚甲基二氧基甲基苯丙胺(MDMA)、裸盖头碱、大麻和苯二氮卓类药物。他承认在过去的8个月里,在使用MDMA期间有幻听和听觉增强,并描述了他在儿童精神科住院的5天里出现的幻听和幻听。阿立哌唑5 mg治疗HPPD。结果:通过文献回顾,在HPPD的一线治疗中,使用氯定和苯二氮卓类药物的病例报道很少。除阿立哌唑外,第二代抗精神病药物的疗效较差。作者见证了患者在使用阿立哌唑后症状的逐渐改善,尽管在住院期间症状没有完全解决。结论:本病例证明了青少年患者HPPD的表现和阿立哌唑的疗效。患者使用多种药物的历史使诊断进一步复杂化,并确定与非药物引起的精神障碍的区别是至关重要的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信